Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
04/2004
04/01/2004WO2004027372A2 Method for diagnosing rhabdomyosarcoma and pharmaceutical compositions for the treatment and/or prevention of rhabdomyosarcoma
04/01/2004WO2004027053A1 Chicken astrovirus type 2
04/01/2004WO2004027052A1 Th1 cell adoptive immunotherapy
04/01/2004WO2004027049A2 Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells
04/01/2004WO2004027037A2 RECOVERY OF RECOMBINANT HUMAN PARAINFLUENZA VIRUS TYPE 2 (HPIV2) FROM cDNA AND USE OF RECOMBINANT HPIV2 IN IMMUNOGENIC COMPOSITIONS AND AS VECTORS TO ELICIT IMMUNE RESPONSES AGAINST PIV AND OTHER HUMAN PATHOGENS
04/01/2004WO2004027036A2 Cancer immunotherapy with a viral antigen-defined, immunomodulator-secreting cell vaccine
04/01/2004WO2004026905A2 Transporter/channel proteins
04/01/2004WO2004026901A1 M. paratuberculosis specific abc-transporter operon
04/01/2004WO2004026900A1 Vaccine
04/01/2004WO2004026899A1 Immunogen for preparation of therapeutic vaccines or drugs for treatment of hepatitis b and the producing method and use thereof
04/01/2004WO2004026427A2 Isolation of immunoglobulin molecules that lack inter-heavy chain disulfide bonds
04/01/2004WO2004026338A1 Ihnv g protein for immune stimulation
04/01/2004WO2004026337A1 Combination treatment of cancer using a cancer vaccine and a chemotherapeutic drug
04/01/2004WO2004026336A1 Improvements in or relating to vaccines
04/01/2004WO2004026265A2 Compositions and methods for treatment of herpesvirus infections
04/01/2004WO2004026260A2 Prophylactic and therapeutic hiv aptamers
04/01/2004WO2004026250A2 Re-activated t-cells for adoptive immunotherapy
04/01/2004WO2004026240A2 Animal immunocontraceptives expressed in plants and uses thereof
04/01/2004WO2004026238A2 Immunotherapeutic compositions and methods for the treatment of moderately to well-differentiated cancers
04/01/2004WO2004026120A2 Methods for diagnosing and treating tumors and suppressing cd promoters
04/01/2004WO2004026024A2 Vaccine compositions and adjuvant
04/01/2004WO2004018681A3 Il-7 drug substance, il- 7 comprising composition, preparation and uses thereof
04/01/2004WO2004015056A3 Immunomodulating compositions, processes for their production and uses therefor
04/01/2004WO2004013631A3 Compositions and methods for diagnosis and therapy of cancer
04/01/2004WO2004007723A3 Genes
04/01/2004WO2004005473A3 Hcv fusion proteins with modified ns3 domains
04/01/2004WO2004004639A3 A novel stable formulation
04/01/2004WO2004003153A8 Live replicating spumavirus vector
04/01/2004WO2003102219A9 Improved pseudotyped retroviruses
04/01/2004WO2003099868B1 Method for obtaining anti-idiotype antibodies
04/01/2004WO2003095642A3 Polyepitopes and mini-genes for cancer treatment
04/01/2004WO2003095476A3 PEPTIDES FOR REGULATION OF UROKINASE (uPA) AND TISSUE TYPE (tPA) PLASMINOGEN ACTIVATOR AND METHOD OF OPTIMIZING THERAPEUTIC EFFICACY
04/01/2004WO2003091383A3 Epha2 antigen t epitopes
04/01/2004WO2003090667A3 Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the hpv-16 virus
04/01/2004WO2003087840A3 Protein involved in cancer
04/01/2004WO2003084540A3 Compositions comprising mmp7 modulators for the treatment of chronic pain
04/01/2004WO2003082314A3 Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1)
04/01/2004WO2003074078A3 Cg3842 homologous proteins involved in the regulation of energy homeostasis
04/01/2004WO2003073828A3 Immunotherapy for prostate cancer using recombinant bacille calmette-guerin expressing prostate specific antigens
04/01/2004WO2003072029A3 Methods of extending corneal graft survival
04/01/2004WO2003066877A3 Compositions and methods relating to hepatic specific genes and proteins
04/01/2004WO2003064446A3 Plasma protein-binding peptides from bacterial curli
04/01/2004WO2003063792A3 Compositions and methods related to tim-3, a th1-specific cell surface molecule
04/01/2004WO2003063770A3 Expression vectors encoding epitopes of target-associated antigens and methods for their design
04/01/2004WO2003060090A3 Novel cytokine zcytor17 ligand
04/01/2004WO2003050283A3 A structure for presenting desired peptide sequences
04/01/2004WO2003048186A3 Surface simulation synthetic peptides useful in the treatment of hyper-variable viral pathogens
04/01/2004WO2003030965A3 Artificial lymph node
04/01/2004WO2003029282A3 Tumor-peptide antigens from the human prdi-bf1-protein
04/01/2004WO2003025019A8 Anti-pdgf antibodies and methods for producing engineered antibodies
04/01/2004WO2003014161A9 Antigen binding domains from fish
04/01/2004WO2002077012A3 Human papilloma virus immunoreative peptides
04/01/2004WO2002070676A9 Use of protein histidine phosphatase
04/01/2004WO2002064131A3 Inflammation-inhibiting compounds
04/01/2004WO2002060485A9 Use of immunoregulatory antibodies in the treatment of neoplastic disorders
04/01/2004US20040063921 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/01/2004US20040063914 Antibodies against phosphorylated VASP ( vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use
04/01/2004US20040063913 Antibodies to human il-1beta
04/01/2004US20040063908 Comprises genetically engineered hemophilus adherence and penetration (HAP) proteins for treatment and prevention of influenza; immunotherapy
04/01/2004US20040063652 Introducing multiple nucleic acid molecules simultaneously without deletereous effects; controlling level of expression
04/01/2004US20040063647 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors
04/01/2004US20040063632 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
04/01/2004US20040063610 For therapy of mammal having a transected peripheral nerve or injured spinal cord
04/01/2004US20040063190 Preparation and usage of plasmodium fusion antigen
04/01/2004US20040063188 Kit for treating gastrointestinal tract
04/01/2004US20040063178 Comprises enzymatic polypeptide for identifying modulators of leukocyte adhesion and treatments of inflammatory diseases l
04/01/2004US20040063156 Materials and methods relating to the diagnosis and treatment of diabetes and obesity
04/01/2004US20040063140 Methods for diagnosis of cancer using erbB-3
04/01/2004US20040063135 Comprises oligonucleotides for determining concentration of glucuonidase in cell culture; detection and monitoring of malignancies and metastasis; targeted drug delivery
04/01/2004US20040063131 Comprises neuroendocrine-specific proteins-like polypeptides (NSPLP) for diagnosis, prevention and treatment of neurodegenerative and cell proliferative diseases
04/01/2004US20040063095 gM-negative EHV-mutants
04/01/2004US20040062777 Genetic engineered polypeptides; enzyme inhibitors
04/01/2004US20040062775 Nucleotide sequences; veterinary medicine; vaccine
04/01/2004US20040062774 Multiple epitope immunoglobulin for prevention and/or treatment of mastitis; bactericides
04/01/2004US20040062773 Compositions for the delivery of antigens
04/01/2004US20040062772 Attenuated live neospora vaccine
04/01/2004US20040062771 Clostridial toxin disease therapy
04/01/2004US20040062769 Identification of the domain of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) that mediates adhesion to chondroitin sulfate A
04/01/2004US20040062768 Compositions and methods for treating hyperimmune response in the eye
04/01/2004US20040062766 Cell separation compositions and methods
04/01/2004US20040062762 Method of sterilizing antibody-containing milk and products containing sterilized antibody-containing milk
04/01/2004US20040062761 Nucleic acid and corresponding protein entitled 151P3D4 useful in treatment and detection of cancer
04/01/2004US20040062760 Human complement C3-binding protein from streptococcus pneumoniae
04/01/2004US20040062716 Aerosol; high speed absorption; mixture of solvent and active materials
04/01/2004US20040060568 Hedgehog antagonists, methods and uses related thereto
04/01/2004CA2499995A1 Compositions and methods for treatment of herpesvirus infections
04/01/2004CA2499628A1 Combination treatment of cancer using a cancer vaccine and a chemotherapeutic drug
04/01/2004CA2499470A1 Animal immunocontraceptives expressed in plants and uses thereof
04/01/2004CA2499404A1 Recovery of recombinant human parainfluenza virus type 2 (hpiv2) from cdna and use of recombinant hpiv2 in immunogenic compositions and as vectors to elicit immune responses against piv and other human pathogens
04/01/2004CA2499269A1 Isolation of immunoglobulin molecules that lack inter-heavy chain disulfide bonds
04/01/2004CA2499066A1 Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells
04/01/2004CA2498896A1 Ihnv g protein for immune stimulation
04/01/2004CA2498325A1 Prophylactic and therapeutic hiv aptamers
04/01/2004CA2497878A1 Improvements in or relating to vaccines
04/01/2004CA2497554A1 Immunotherapeutic compositions and methods for the treatment of moderately to well-differentiated cancers
03/2004
03/31/2004EP1403643A1 Lawsonia intracellularis cultivation, anti-lawsonia intracelluaris vaccines and diagnostic agents
03/31/2004EP1403375A2 Recombinant live avian vaccin, using avian herpes virus as vector
03/31/2004EP1403283A1 Tumor antigen
03/31/2004EP1403280A1 Hypoallergenic allergy vaccines based on the timothy grass pollen allergen Phl p 7
03/31/2004EP1402267A1 Chp for use as marker for sepsis-type inflammatory diseases